Cleared Traditional

Blood pressure monitor (K232621) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K232621 · Guangdong Transtek Medical Electronics Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2023
Decision
85d
Days
Class 2
Risk

K232621 is an FDA 510(k) clearance for the Blood pressure monitor. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Guangdong Transtek Medical Electronics Co., Ltd. (Zhongshan, CN). The FDA issued a Cleared decision on November 22, 2023 after a review of 85 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Guangdong Transtek Medical Electronics Co., Ltd. devices

Submission Details

510(k) Number K232621 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 29, 2023
Decision Date November 22, 2023
Days to Decision 85 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
40d faster than avg
Panel avg: 125d · This submission: 85d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 269
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K232621.
Digital Blood Pressure Monitor
K231250 · Guangdong Genial Technology Co., Ltd. · Nov 2023
Blood Pressure Monitor
K232713 · Guangdong Transtek Medical Electronics Co., Ltd. · Nov 2023
Digital Blood Pressure Monitor (Arm Type)
K231245 · Guangdong Genial Technology Co., Ltd. · Nov 2023
Electronic Blood Pressure Monitor
K231310 · Shenzhen Jumper Medical Equipment Co., Ltd. · Oct 2023
Acumen IQ finger cuff
K230919 · Edwards Lifesciences, LLC · Oct 2023
Arm Blood Pressure Monitor
K231050 · Alicn Medical (Shenzhen), Inc. · Oct 2023